Clinical Trial Update: A Study of GR1802 Injection in Patients With Seasonal Allergic Rhinitis. [Phase 3]

View source ↗

Summary

Clinical trial update indicating a Phase 3 study of GR1802 injections for seasonal allergic rhinitis is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• GR1802 (GR1802)

Snippet

Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd. | Conditions: Allergic Rhinitis, Seasonal | Phase 3 | Status: NOT_YET_RECRUITING